Quality White Papers & Case Studies

  1. Robust Database Characterizes And Optimizes Product Development 8/29/2026

    Integrating material characterization data with process parameters accelerates drug development, reduces empirical testing, and strengthens regulatory compliance.

  2. The Automation Advantage: Reducing Risk In Cell Therapy Production 8/29/2026

    Automated bioprocessing platforms transform complex cell therapy workflows into scalable, fully compliant manufacturing pathways to lower costs and expand access.

  3. Determining The True Cost Of Single-Use Fluid Management 8/24/2026

    Looking beyond unit price reveals how reliability, leak prevention, and shelf life affect bioprocessing costs. Make purchasing decisions that support resilient and predictable operations.

  4. Increase Throughput For Intact Mass Confirmation And Impurity Screening 8/24/2026

    Accelerate intact mass analysis of GLP-1 analogues with automated purity calculations, sub-ppm mass accuracy, and impurity detection for consistent results in under one minute per sample.

  5. Improving AAV Manufacturing: Advancements In Full Capsid Enrichment 8/19/2026

    As AAV manufacturing matures, integrated optimization of capture, buffer chemistry, load conditioning, and AEX polishing enables scalable full capsid enrichment, improving product quality and manufacturability.

  6. Systemic Modularity: A Roadmap To Flexible, Efficient Biopharmaceutical Manufacturing 8/13/2026

    Modernizing biomanufacturing requires shifting from rigid, custom setups toward modular automation, data-rich sensors, and plug-and-produce operations. 

  7. Efficient Clone Screening With Increased Process Control And Integrated Cell Health And Titer Measurements With The Cydem VT Automated Clone Screening System 8/12/2026

    Automated screening of antibody-producing clones provides real-time cell health and titer data, helping developers identify top-performing candidates earlier and with confidence.

  8. GLP-1 Peptides Around The World 8/12/2026

    Explore how evolving regulations, supply constraints, and reimbursement models shape GLP-1 drug development across the U.S., Europe, and Asia.

  9. Manufacturing Readiness: Why Compliance Is Won Or Lost On The Floor 8/6/2026

    Achieve continuous regulatory readiness by embedding ALCOA++ compliance directly into manufacturing workflows to eliminate paper-based documentation risks.

  10. ElevateBio BaseCamp Cleanroom Expansion 7/30/2026

    Expanding active cleanrooms risks environmental stability. A risk-based commissioning strategy protects ongoing production, verifies HVAC performance, and streamlines qualification timelines.